Gregor Reiter

Gregor Reiter


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2024 in Journal of Orthopaedic Trauma
Verified
Journal Article
Open access
HFHolger Freischmidt
Holger Freischmidt
TGThorsten Guehring
Thorsten Guehring
PTPatrick Msc Thomé
Patrick Msc Thomé
JAJonas Armbruster
Jonas Armbruster
GRGregor Reiter
Gregor Reiter
Philip-Christian NoltePhilip-Christian Nolte
Philip-Christian Nolte
OBJECTIVES: The purposes of this study were to assess clinical and radiographic outcomes following plate-assisted bone segment transport (PABST) in large bone defects of the lower extremities. METHODS: Design: Retrospective study of prospectively collected data. Setting: Level-1 trauma center located in Germany. Patient Selection Criteria: Patients who underwent PABST and were at least 1 year postoperatively were included. Outcome Measures and Comparisons: Demographic data were collected. Radiographic apparent bone gap (RABG), time to consolidation, time to full weight-bearing, and consolidation index were calculated. Numeric rating scale, lower extremity functional scale (LEFS), and complications were assessed. RESULTS: Fifteen patients [13 male; mean age 51 years (range, 20–75)] underwent PABST and had follow-up at a mean of 29.1 months. The tibia was affected in 8 and the femur in 7 patients. Preoperative RABG was 60 mm [interquartile range (IQR): 40–125], and bone defects were caused by septic nonunions in 73% of patients. Fourteen patients (93%) demonstrated consolidated transport callus at 7.3 months [95% confidence interval (95% CI), 6–8.5], and 9 patients (60%) demonstrated complete consolidation of both docking site and transport callus at 11.5 months (95% CI, 7.3–15.3). Postoperative RABG was 0.1 mm (IQR: 0–0.8), and consolidation index was 1.9 months/cm (95% CI, 1.3–2.5). All patients achieved full weight-bearing at 8.7 months (IQR: 6.5–10.3). LEFS was 42 (95% CI, 34–50), and numeric rating scale was 3 (95% CI, 2–4). Patients treated for tibial defects had a significantly higher consolidation rate compared with patients treated for femoral defects (P = 0.040). CONCLUSIONS: PABST demonstrated high consolidation of transport callus with few complications. Although full weight-bearing was achieved in all patients, complete consolidation of the docking site was only present in 60% of cases. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

19 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JAJonas Armbruster
Jonas Armbruster
FBFlorian Bussmann
Florian Bussmann
HFHolger Freischmidt
Holger Freischmidt
GRGregor Reiter
Gregor Reiter
Paul Alfred GrütznerPaul Alfred Grützner
Paul Alfred Grützner
JBJan Siad El Barbari
Jan Siad El Barbari
Background/Objectives: Traditional autologous bone grafts as a treatment for bone defects have drawbacks like donor-site morbidity and limited supply. PerOssal®, a ceramic bone substitute, may overcome those drawbacks and could offer additional benefits like prolonged, local antibiotic release. This study investigates the clinical and radiological outcomes, including patient-reported outcomes, of using PerOssal® in nonunions (NU) and high-grade chronic osteomyelitis (COM). Methods: A single-center, retrospective study, investigating patients treated with PerOssal® between January 2020 and December 2023. Collected data include patient characteristics as well as various surgical and outcome parameters including the Lower Extremity Functional Scale (LEFS). Results: A total of 82 patients were analyzed. Reinfection occurred in 19.5% of cases. Osseous integration of PerOssal® was achieved in 89% of cases, higher in cavitary defects (91.5%) than segmental defects (72.7%). The revision rate was 32.9%, mainly due to wound healing disorders and reinfections. Mean LEFS score was 53.4 which was heavily influenced by sex (male: 50.7 vs. female: 63.4), revision surgery (no: 55.7 vs. yes: 49.1), reinfection (no: 56.6 vs. yes: 39.4), and osseous integration of PerOssal® (yes: 55.8 vs. no: 38.4). Conclusions: PerOssal® demonstrates promising outcomes in treating NUs and high-grade COM, especially in cavitary defects, with high osseous integration rates and acceptable functional results. However, reinfection remains a concern, particularly with difficult-to-treat pathogens and extensive surgical histories. Early, comprehensive surgical intervention and tailored antibiotic strategies are essential. Patient selection, defect characteristics, and comorbidities significantly influence success. Further research is needed to optimize treatment protocols.

9 September 2019 in Der Chirurg
Verified
Journal Article
Closed access
PDF file
GRGregor Reiter
Gregor Reiter
BTB. Thomas
B. Thomas
CKC. Kühner
C. Kühner
GHG. Hundeshagen
G. Hundeshagen
FWF. Weil
F. Weil
UKU. Kneser
U. Kneser

28 August 2019 in Der Chirurg
Verified
Journal Article
Closed access
PDF file
GRGregor Reiter
Gregor Reiter
FWF. Weil
F. Weil
BTB. Thomas
B. Thomas
CKC. Kühner
C. Kühner
GWG. Wittenberg
G. Wittenberg
UKU. Kneser
U. Kneser

28 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JAJonas Armbruster
Jonas Armbruster
FBFlorian Bussmann
Florian Bussmann
HFHolger Freischmidt
Holger Freischmidt
GRGregor Reiter
Gregor Reiter
Paul Alfred GrütznerPaul Alfred Grützner
Paul Alfred Grützner
JBJan Siad El Barbari
Jan Siad El Barbari
Background/Objectives: Traditional autologous bone grafts as treatment for bone defects have drawbacks like donor-site morbidity and limited supply. PerOssal®, a ceramic bone substitute may overcome those drawbacks and could offer additional benefits like prolonged, local antibiotic release. This study investigates the clinical and radiological outcomes, including patient-reported outcomes, of using PerOssal® in nonunions (NU) and high-grade chronic osteomyelitis (COM). Methods: Single-center, retrospective study, investigating patients treated with PerOssal® between January 2020 and December 2023. Collected data included patient characteristics as well as various surgical and outcome parameters including the Lower Extremity Functional Scale (LEFS). Results: A total of 82 patients were analyzed. Reinfection occurred in 19.5% of cases. Osseous integration of PerOssal® was achieved in 89% of cases, higher in cavitary defects (91.5%) than segmental defects (72.7%). The revision rate was 32.9%, mainly due to wound healing disorders and reinfections. Mean LEFS score was 53.4 which was heavily influenced by sex (male: 50.7 vs. female: 63.4), revision surgery (no: 55.7 vs. yes: 49.1), reinfection (no: 56.6 vs. yes: 39.4), and osseous integration of PerOssal® (yes: 55.8 vs. no: 38.4). Conclusions: PerOssal® demonstrates promising outcomes in treating NUs and high-grade COM, especially in cavitary defects, with high osseous integration rates and acceptable functional results. However, reinfection remains a concern, particularly with difficult-to-treat pathogens and extensive surgical histories. Early, comprehensive surgical intervention and tailored antibiotic strategies are essential. Patient selection, defect characteristics, and comorbidities significantly influence success. Further research is needed to optimize treatment protocols.

15 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JAJonas Armbruster
Jonas Armbruster
Eva Simone SteinhausenEva Simone Steinhausen
Eva Simone Steinhausen
Simon HacklSimon Hackl
Simon Hackl
MRMarie K. Reumann
Marie K. Reumann
DSDirk Stengel
Dirk Stengel
HFHolger Freischmidt
Holger Freischmidt
Background/Objectives: Although extensive research on risk factors for nonunion development has been published, clinicians frequently rely on heuristic reasoning—intuitive, experience-based decision-making—to predict nonunions. However, the accuracy of these intuitive assessments and the influence of clinician experience remain uncertain. This study aims to assess clinicians’ diagnostic accuracy in predicting nonunion, investigate the impact of experience on predictive performance, and identify patient-specific factors contributing to diagnostic errors. Methods: This retrospective, multi-center cohort study included 98 patients with surgically treated tibial shaft fractures between 2018 and 2023 from four level-one trauma centers in Germany. Fracture outcomes were classified as either nonunion (n = 20) or regular fracture healing (n = 78). Patient cases were presented to 24 clinicians. Each clinician independently assessed preoperative and postoperative biplanar X-rays and patient histories to predict fracture healing. Results: Clinicians’ sensitivity significantly improved from 50.4% to 60.2%, while specificity declined (74.0% to 70.7%) with the addition of postoperative information. No significant differences in predictive performance were observed across different levels of clinician experience. Changes in assessment after reviewing postoperative information were equally likely to be beneficial or detrimental. Certain patient factors, including obesity and smoking, influenced prediction errors. Conclusions: This study is the first to assess heuristic reasoning in nonunion prediction. The findings suggest that clinician experience does not significantly enhance diagnostic accuracy under limited-information conditions. Patients should be informed that predicting individual nonunion risk remains challenging. Larger studies are needed to explore the role of patient-specific factors and refine clinical decision-making in fracture healing prognosis.